Institutional Review Board Statement
The study was conducted in accordance with the Declaration of Helsinki, and approved by Clinical Research Ethics Committee of the Health Area of Burgos and Soria (Spain), with reference number CEIM-2119/2019 before participating in the present study on 25 March 2021 (ClinicalTrials.gov test number: NCT04815382).